{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:14:17Z","timestamp":1762431257512},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12894-017-0198-2","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T05:18:55Z","timestamp":1484111935000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer"],"prefix":"10.1186","volume":"17","author":[{"given":"G.","family":"Hatiboglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. V.","family":"Popeneciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Deppert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Nyarangi-Dix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Hadaschik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hohenfellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Teber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pahernik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"issue":"1","key":"198_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","volume":"59","author":"A Heidenreich","year":"2011","unstructured":"Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol. 2011;59(1):61\u201371. doi: 10.1016\/j.eururo.2010.10.039 .","journal-title":"Eur Urol"},{"issue":"6","key":"198_CR2","first-page":"493","volume":"64","author":"CG Chaussy","year":"2011","unstructured":"Chaussy CG, Thuroff S. Transrectal high-intensity focused ultrasound for local treatment of prostate cancer: current role. Arch Esp Urol. 2011;64(6):493\u2013506.","journal-title":"Arch Esp Urol"},{"issue":"8","key":"198_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1089\/089277903322518680","volume":"17","author":"S Madersbacher","year":"2003","unstructured":"Madersbacher S, Marberger M. High-energy shockwaves and extracorporeal high-intensity focused ultrasound. J Endourol. 2003;17(8):667\u201372. doi: 10.1089\/089277903322518680 .","journal-title":"J Endourol"},{"issue":"15","key":"198_CR4","first-page":"3346","volume":"55","author":"S Madersbacher","year":"1995","unstructured":"Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res. 1995;55(15):3346\u201351.","journal-title":"Cancer Res"},{"issue":"5","key":"198_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.eururo.2013.04.039","volume":"65","author":"S Crouzet","year":"2014","unstructured":"Crouzet S, Chapelon JY, Rouviere O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H, et al. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol. 2014;65(5):907\u201314. doi: 10.1016\/j.eururo.2013.04.039 .","journal-title":"Eur Urol"},{"issue":"2","key":"198_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/1758834010395342","volume":"3","author":"D Osoba","year":"2011","unstructured":"Osoba D. Health-related quality of life and cancer clinical trials. Ther Adv Med Oncol. 2011;3(2):57\u201371. doi: 10.1177\/1758834010395342 .","journal-title":"Ther Adv Med Oncol."},{"issue":"12","key":"198_CR7","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1200\/JCO.2005.07.116","volume":"23","author":"DC Miller","year":"2005","unstructured":"Miller DC, Sanda MG, Dunn RL, Montie JE, Pimentel H, Sandler HM, et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol. 2005;23(12):2772\u201380. doi: 10.1200\/JCO.2005.07.116 .","journal-title":"J Clin Oncol"},{"key":"198_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-014-0419-6","author":"FJ Drummond","year":"2015","unstructured":"Drummond FJ, Kinnear H, O'Leary E, Donnelly, Gavin A, Sharp L. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study. J Cancer Surviv. 2015. doi: 10.1007\/s11764-014-0419-6 .","journal-title":"J Cancer Surviv"},{"issue":"4","key":"198_CR9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0895-4356(96)00428-3","volume":"50","author":"M Groenvold","year":"1997","unstructured":"Groenvold M, Klee MC, Sprangers MA, Aaronson NK. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol. 1997;50(4):441\u201350.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"198_CR10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF00449426","volume":"2","author":"HE Niezgoda","year":"1993","unstructured":"Niezgoda HE, Pater JL. A validation study of the domains of the core EORTC quality of life questionnaire. Qual Life Res. 1993;2(5):319\u201325.","journal-title":"Qual Life Res"},{"issue":"3","key":"198_CR11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11934-003-0077-0","volume":"4","author":"C Chaussy","year":"2003","unstructured":"Chaussy C, Thuroff S. The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection. Curr Urol Rep. 2003;4(3):248\u201352.","journal-title":"Curr Urol Rep"},{"issue":"11","key":"198_CR12","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1200\/JCO.2003.01.075","volume":"21","author":"AV D'Amico","year":"2003","unstructured":"D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol. 2003;21(11):2163\u201372. doi: 10.1200\/JCO.2003.01.075 .","journal-title":"J Clin Oncol"},{"issue":"11","key":"198_CR13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D'Amico","year":"1998","unstructured":"D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280(11):969\u201374.","journal-title":"JAMA"},{"issue":"8 Pt 2","key":"198_CR14","doi-asserted-by":"publisher","first-page":"E196","DOI":"10.1111\/j.1464-410X.2011.10091.x","volume":"108","author":"R Ganzer","year":"2011","unstructured":"Ganzer R, Robertson CN, Ward JF, Brown SC, Conti GN, Murat FJ, et al. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry. BJU Int. 2011;108(8 Pt 2):E196\u2013201. doi: 10.1111\/j.1464-410X.2011.10091.x .","journal-title":"BJU Int"},{"issue":"4","key":"198_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","volume":"65","author":"M Roach 3rd","year":"2006","unstructured":"Roach 3rd M, Hanks G, Thames Jr H, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65(4):965\u201374. doi: 10.1016\/j.ijrobp.2006.04.029 .","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"198_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"11","key":"198_CR17","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/j.1464-410X.2012.11375.x","volume":"110","author":"D Pfeiffer","year":"2012","unstructured":"Pfeiffer D, Berger J, Gross AJ. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes. BJU Int. 2012;110(11):1702\u20137. doi: 10.1111\/j.1464-410X.2012.11375.x .","journal-title":"BJU Int"},{"issue":"6","key":"198_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.eururo.2010.09.009","volume":"58","author":"M Warmuth","year":"2010","unstructured":"Warmuth M, Johansson T, Mad P. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer. Eur Urol. 2010;58(6):803\u201315. doi: 10.1016\/j.eururo.2010.09.009 .","journal-title":"Eur Urol"},{"issue":"6","key":"198_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.urology.2008.06.062","volume":"72","author":"A Blana","year":"2008","unstructured":"Blana A, Rogenhofer S, Ganzer R, Lunz JC, Schostak M, Wieland WF, et al. Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. Urology. 2008;72(6):1329\u201333. doi: 10.1016\/j.urology.2008.06.062 . discussion 33\u20134.","journal-title":"Urology"},{"issue":"3","key":"198_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1464-410X.2012.11715.x","volume":"112","author":"R Ganzer","year":"2013","unstructured":"Ganzer R, Fritsche HM, Brandtner A, Brundl J, Koch D, Wieland WF, et al. Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer. BJU Int. 2013;112(3):322\u20139. doi: 10.1111\/j.1464-410X.2012.11715.x .","journal-title":"BJU Int"},{"issue":"3","key":"198_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11934-011-0184-2","volume":"12","author":"CG Chaussy","year":"2011","unstructured":"Chaussy CG, Thuroff SF. Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15\u00a0years of clinical use? Curr Urol Rep. 2011;12(3):180\u20137. doi: 10.1007\/s11934-011-0184-2 .","journal-title":"Curr Urol Rep"},{"issue":"4","key":"198_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1089\/089277901300189501","volume":"15","author":"C Chaussy","year":"2001","unstructured":"Chaussy C, Thuroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol. 2001;15(4):437\u201340. doi: 10.1089\/089277901300189501 . discussion 47\u20138.","journal-title":"J Endourol"},{"key":"198_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2147\/VHRM.S26712","volume":"8","author":"RM Burke","year":"2012","unstructured":"Burke RM, Evans JD. Avanafil for treatment of erectile dysfunction: review of its potential. Vasc Health Risk Manag. 2012;8:517\u201323. doi: 10.2147\/VHRM.S26712 .","journal-title":"Vasc Health Risk Manag"},{"issue":"8","key":"198_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1442-2042.2010.02568.x","volume":"17","author":"S Shoji","year":"2010","unstructured":"Shoji S, Nakano M, Nagata Y, Usui Y, Terachi T, Uchida T. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study. Int J Urol. 2010;17(8):715\u20139. doi: 10.1111\/j.1442-2042.2010.02568.x .","journal-title":"Int J Urol"},{"issue":"11","key":"198_CR25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0959-8049(00)00447-0","volume":"37","author":"R Schwarz","year":"2001","unstructured":"Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37(11):1345\u201351.","journal-title":"Eur J Cancer"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-017-0198-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T07:54:02Z","timestamp":1498377242000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-017-0198-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["198"],"URL":"https:\/\/doi.org\/10.1186\/s12894-017-0198-2","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]},"article-number":"5"}}